Skip to content

Comic Art Creation as Supportive Care in Cancer Patients and Caregivers

A Pilot Study to Test the Feasibility of Comic Art Creation for Symptom Management in Cancer Supportive Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03067766
Enrollment
8
Registered
2017-03-01
Start date
2017-08-24
Completion date
2019-02-08
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver, Malignant Neoplasm

Brief summary

This pilot clinical trial studies how well comic art creation works as supportive care in cancer patients and caregivers. Participating in a comic art creation workshop may help patients and their family members or friends share their medical experience through storytelling and drawings in a way that can, but does not have to, reflect the real world. It may also help improve emotional wellbeing and communication in cancer patients and caregivers.

Detailed description

PRIMARY OBJECTIVES: I. To determine the feasibility of using a 10 week (Workshop A) or a 5 week (Workshops B-C) comic art creation workshops for supportive care. II. To determine the feasibility of studying comic art creation workshops for supportive care. III. To describe those factors affecting the ability or inability of participants to engage in the workshop. SECONDARY OBJECTIVES: I. To describe changes in emotional wellbeing and communication of patients and caretakers/family/friends. TERTIARY OBJECTIVES: I. Identify the methods that most engage supportive care patients and caretakers. II. Identify the social and cultural interactions most impacted by comics creation. III. To describe participant feedback regarding the intervention and study design. OUTLINE: Patients are assigned to 1 of 2 arms. WORKSHOP A: Patients and a family member, caretaker, or friend participate in an artist-led comic art therapy workshop over 2 hours once a week for 10 weeks. Patients and participants receive a range of assignments that focus on creative art and experimentation with materials and storytelling in order to make a series of small handmade books that relate directly or indirectly to their experience with cancer. Patients undergo a qualitative interview over approximately 45 minutes and complete validated questionnaires within 4 weeks prior to the workshop and midway through the workshop. WORKSHOPS B AND C: Patients participate in an artist-led comic art therapy workshop over 3 hours once a week for 5 weeks. Patients receive a range of assignments that focus on creative art and experimentation with materials and storytelling in order to make a series of small handmade books that relate directly or indirectly to their experience with cancer. Patients undergo a qualitative interview over approximately 45 minutes and complete validated questionnaires within 4 weeks prior to the workshop. After completion of the study, patients are followed up at 1 and 6 weeks.

Interventions

PROCEDUREArt Therapy

Participate in a comic art creation workshop

OTHERInterview

Undergo qualitative interviews

PROCEDUREQuality-of-Life Assessment

Ancillary studies

OTHERQuestionnaire Administration

Ancillary studies

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
City of Hope Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Documented written informed consent of the participant * Workshop A (2017 - 10 weeks- City of Hope) * Either one of the following: * City of Hope (COH) cancer patient (all types and at any time point of their disease) OR * Caretaker/friend family member of the cancer patient * Workshops B and C (2018 - 5 weeks - City of Hope) * Cancer patients (all types and at any time point in their disease) * Note: documentation to confirm this eligibility criteria will not be requested; self-reporting as a cancer patient will be considered adequate * Ability read and speak English * Willingness and ability to complete the entire workshop, including the interviews and questionnaires (there is no predetermined qualification with regard to the ability to hold an artist tool; accommodations and creative solutions will be made to facilitate participation)

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the comic art creation workshop defined as participant completion and psychosocial value of the comic artUp to 1.5 yearsThe project will be considered feasible if most of the participants complete the study and consider the comic art to have personal meaning, and if an initial power calculation indicates that a sufficiently powered randomized controlled trial is possible given the resources of the study team. It is anticipated that the psychosocial value of the art will be largely derived from the internal creation process and further assessment of the artistic products will not be conducted.

Secondary

MeasureTime frameDescription
Change in anxiety and depression as measured by the Hospital Anxiety and Depression Scale questionnaireBaseline to up to 6 weeks post-workshopStatistical analysis will include Wilcoxon signed ranks test of pre, mid and post workshop HRQOL and symptom assessments. The Friedman test will be used to measure magnitude of difference within a case.
Change in health-related quality of life (HRQOL) as measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30Baseline to up to 6 weeks post-workshopStatistical analysis will include Wilcoxon signed ranks test of pre, mid and post workshop HRQOL and symptom assessments. The Friedman test will be used to measure magnitude of difference within a case.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026